Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,475,276
+$42,191 QoQ
Shares Held
4,074
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,442
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. AMGN ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
4,074 | $1,475,276 | |
| 2 | ABBV |
AbbVie Inc.
|
5,785 | $1,455,737 | |
| 3 | JNJ |
Johnson & Johnson
|
4,993 | $1,268,072 | |
| 4 | LLY |
ELI LILLY & Co
|
768 | $921,162 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,878 | $626,823 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
744 | $93,996 | |
| 7 | NVO |
Novo Nordisk A S
|
1,841 | $88,257 | |
| 8 | PFE |
Pfizer Inc
|
881 | $21,214 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,475,276 | 4,074 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,433,085 | 4,073 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,333,133 | 4,073 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,132,186 | 4,012 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,109,022 | 3,972 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1,265,204 | 4,061 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,058,719 | 4,062 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,334,593 | 4,142 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,292,293 | 4,136 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,175,947 | 4,136 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,191,250 | 4,136 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,083,371 | 4,031 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $894,962 | 4,031 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $981,505 | 4,060 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $849,640 | 3,235 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $732,550 | 3,250 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $781,722 | 3,213 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $776,967 | 3,213 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $722,828 | 3,213 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $683,244 | 3,213 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $783,168 | 3,213 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $799,426 | 3,213 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $775,750 | 3,374 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $844,827 | 3,324 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $806,641 | 3,420 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $693,336 | 3,420 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||